Ciencias de la vida

CONJUGATES OF A MICROPEPTIDE KILLSWITCH
18/11/2026 - Przedmiotem zgłoszenia jest tiokarbonylowy analog flawonu o wzorze: TF-(O-R)k(O-R)'m(O-R")n, w którym TF oznacza strukturę 2-fenylo-chromen-4-tionu; O-R, O-R' oraz O-R" oznacza grupę...
LCP1 PEPTIDES WITH ANTITUMOUR ACTIVITY
18/11/2026 - The object of the present invention are polypeptide compounds of formula (I), in neutral form or in the form of salts, aggregates, complexes or solvates, which are able to inhibit the growth and...
HETEROCYCLIC INHIBITORS OF S100A4 TRANSCRIPTION FOR USE IN THE TREATMENT OF CANCER AND METASTASES
18/11/2026 - The invention relates to chemical compounds useful as inhibitors of S100A4 in the treatment of cancer. The invention further relates to the medical use of the chemical compounds in the treatment...
TCRS RECOGNIZING MAGE-A4 AND USES THEREOF
18/11/2026 - [0001] The invention relates to a selection of verified targets for T-cell receptors (TCR) against mutated human melanoma-associated antigen A4 (MAGE-A4) peptide, as well as to several new...
VIRTUAL REALITY SYSTEM FOR ASSESSING VISUAL HALLUCINATIONS
29/10/2026 - A system for assessing visual perceptive function includes a virtual reality (VR) device configured to display virtual environments, an eye tracking component associated with the VR device, and a...
AMINE-SUBSTITUTED POLYCYCLIC FLUORESCENCE QUENCHER DYES
18/11/2026 - [0001] The present invention relates to polycyclic compounds of general formula (I), to processes of their preparation, and to the use thereof as fluorescence quenchers in energy-transfer...
COMPOSITIONS CONTAINING ISOLATED PLANT-DERIVED AND ADIPOSE STEM CELL-DERIVED EXOSOMES
29/10/2026 - [0000] The present disclosure provides a composition containing a purified population of extracellular vesicles (EVs) isolated from one or more biological samples, wherein the purified...
METHOD TO EVALUATE ALLOSTERIC INTERACTION
29/10/2026 - The problem that the present invention aims to solve is to provide an objective method to evaluate allosteric interaction. It is assumed that there are no significant differences in the change...
ANALYSIS METHOD AND ANALYSIS DEVICE FOR RESULTS OF MASS SPECTROMETRY OF MICROORGANISM
29/10/2026 - The present invention comprises: a step (ST01) for receiving actually measured data including a plurality of peak data obtained by the mass spectrometry of a microorganism-derived sample; a step...
INHALABLE CANNABIDIOL FORMULATIONS
29/10/2026 - Inhalable powdered cannabidiol formulations and methods of producing the same are provided. The powdered cannabidiol formulations may be used for oral or nasal inhalation.
NANOPARTICLE COATING FORMATION
29/10/2026 - Coating methods are described, for forming a nanoparticle coating on a 5 substrate. The methods involve preparing a positively charged polymer solution comprising a polymer, and forming a layer of...
ANTI-ΑVΒ6 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI- ΑVΒ6 ANTIBODY CONJUGATES AND METHODS OF MAKING AND USING ANTI-ΑVΒ6 ANTIBODY CONJUGATES
12/11/2026 - The present disclosure relates to antibodies and antibody conjugates that selectively bind to αvβ6 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are...
BRM AND BRG1 TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
12/11/2026 - The disclosure is directed to compounds of Formula (IA) Pharmaceutical compositions comprising compounds of Formula (IA), as well as methods of their use and preparation, are also described.
DEXTRAN-BASED PLATFORM FOR TARGETED DELIVERY OF A PAYLOAD
12/11/2026 - The invention relates to a nanoparticle carrier for cell-targeted delivery of one or more therapeutic agent(s) to a mammalian cell, wherein the agent is capable of modulating the properties of a...
FBXO31 LIGANDS
12/11/2026 - This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt thereof) that bind to F-box protein 31 (FBXO31). The FBXO31-binding chemical entities are useful,...
COMPOSITIONS AND METHODS FOR INDUCING AND ENHANCING ANTI-CANCER IMMUNE RESPONSES
12/11/2026 - The present disclosure provides multi-specific binding proteins and uses thereof for inducing and enhancing anti-cancer immune responses in a subject.
ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
12/11/2026 - Compounds of formula (I-A) or (II-A) are provided: wherein R1, R2, n, m, x, R3, R4, R5, R6, u, v, r, LG1, and LG2 have the meanings defined herein. Also provided are synthetic routes for the...
ANTI-AVB6 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-AVB6 ANTIBODIES AND METHODS OF MAKING AND USING ANTI-AVB6 ANTIBODIES
12/11/2026 - The present disclosure relates to antibodies and antibody conjugates that selectively bind to αvβ6 and its isoforms and homologs, and compositions comprising the antibodies and antibody...
MODULATION OF TRANSCRIPTION FACTOR EB ACTIVITY BY N-ACETYL LEUCINE TO TREAT DISORDERS
12/11/2026 - The present disclosure provides methods of activating transcription factor EB (TFEB) activity, modulating lysosomal calcium levels, and/or normalizing calcium signaling in a cell of a subject,...
ANTIBODY MOLECULE TARGETING SYNDECAN-1 FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA AND PLASMACYTOMA
12/11/2026 - Antibody molecule targeting Syndecan-1 for use in the treatment of multiple myeloma and plasmacytoma The invention pertains to an anti-CD138 antibody molecule capable of binding CD138. The...
INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, PROGRAM, AND RECORDING MEDIUM
29/10/2026 - This information processing system comprises a control unit. The control unit acquires an evaluation hair image and/or an evaluation scalp image of a user, evaluates the evaluation hair image...